Spruce Biosciences, Inc. (SPRB)
85.70
+3.03
(+3.67%)
USD |
NASDAQ |
Dec 31, 11:55
Spruce Biosciences EPS Diluted (Quarterly): -14.58 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Mind Medicine (MindMed), Inc. | -0.7832 |
| Annexon, Inc. | -0.3683 |
| Lexeo Therapeutics, Inc. | -0.3326 |
| Arrivent BioPharma, Inc. | -0.8345 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.212M |
| Total Expenses (Quarterly) | 8.212M |
| Enterprise Value | 37.23M |
| Earnings Yield | -71.32% |
| Normalized Earnings Yield | -71.81 |